Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin in Advanced Squamous Carcinoma of the Esophagus
NCT00003864Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Sep 1999
- Primary completion
- Jan 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of docetaxel, carboplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Eastern Cooperative Oncology Group. Started Sep 1999; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT00003864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003864.